Pfizer (PFE)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Pfizer | PFE | Healthcare | Drug Manufacturers - General | 81 | 15.2% |
Current Price ( 4/26 4:01PM EDT) | $25.40 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 58,955.7 | |||
Sales Growth Forecast | 3.4% | |||
Net Profit Margin | 29.0% | |||
Projected Shares Outstanding | 5,648.00 | |||
EPS - Five year Forecast | $3.58 | |||
Average P/E Ratio | 12.0 | |||
Projected Average Price | $42.96 | |||
Price Appreciation (Annualized) | 11.1% | |||
Annual Dividend Yield | 4.1% | |||
Projected Annual Return | 15.2% | |||
Quality | ||||
Financial Strength | 69 | 17.2 | ||
EPS Stability | 70 | 17.6 | ||
Industry Sales Growth Rate | 4.0% | 10.7 | ||
Industry Net Profit Margin | 19.3% | 18.8 | ||
Calculated Quality Rating | 64.2 | |||
Fool CAPS | ||||
Total Players
5617
Outperforms
591
Underperforms
All-Stars (947)
871
Outperforms (92%)
76
Underperforms
|
||||
Fundamental Data Updated: 03/29/2024 |